HomeWebinarsLiver Cancer & Immunohistochemistry

Liver Cancer & Immunohistochemistry

Webinar

What Does it Cover?

Did you know that the incidence of liver cancer has tripled since 1980? Have you wondered what current antibodies are being used to label liver carcinomas by IHC? Or are you curious what antibody grids are used in the differential of primary liver carcinoma? In this presentation, we will discuss the markers used in detecting liver carcinoma as well as other antibody grids that can be run to aid in the identification of primary liver carcinoma.

What Will You Learn?

  • Specific antibodies used to identify liver cancer
  • The antibody grids used for liver carcinomas

Who Should Attend?

  • Pathologists
  • Histotechnologists
  • Pathology Residents
  • Histology Students
  • Lab Managers
  • IHC Technicians
  • Health Care Professionals

Speakers

Brett Merritt

Merck

Account Manager

Brett Merritt has been a Technical Consultant with Cell Marque-Merck for a little over a year. His territory includes PA, NJ, and DE. He was born and raised in the central valley of California where he received his B.S. in Biology. He currently lives in Antelope, CA, near Cell Marque’s headquarters. In his spare time, he is likely to be found with his wife and two kids going on adventures.

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.